Gene · 1365
Papers2,896
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,896
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Quantitative Proteomics for the Identification of Differentially Expressed Proteins in the Extracellular Vesicles of Cervical Cancer Cells. | Viruses | 2023 | 36992411 | PubTator, text mining | PubMed |
| Aspartame and Its Metabolites Cause Oxidative Stress and Mitochondrial and Lipid Alterations in SH-SY5Y Cells. | Nutrients | 2023 | 36986196 | PubTator, text mining | PubMed |
| In Vitro Probiotic Properties of Bifidobacterium animalis subsp. lactis SF and Its Alleviating Effect on Non-Alcoholic Fatty Liver Disease. | Nutrients | 2023 | 36986084 | PubTator, text mining | PubMed |
| Claudin-4: A New Molecular Target for Epithelial Cancer Therapy. | Int J Mol Sci | 2023 | 36982569 | PubTator, text mining | PubMed |
| Combined Effects of Acrylamide and Ochratoxin A on the Intestinal Barrier in Caco-2 Cells. | Foods | 2023 | 36981244 | PubTator, text mining | PubMed |
| Dexamethasone Selectively Inhibits Detachment of Metastatic Thyroid Cancer Cells during Random Positioning. | Cancers (Basel) | 2023 | 36980530 | PubTator, text mining | PubMed |
| Gut microbiota and Autism Spectrum Disorder: From pathogenesis to potential therapeutic perspectives. | J Tradit Complement Med | 2023 | 36970459 | PubTator, text mining | PubMed |
| Downregulation of angulin-1/LSR induces malignancy via upregulation of EGF-dependent claudin-2 and TGF-β-dependent cell metabolism in human lung adenocarcinoma A549 cells. | Oncotarget | 2023 | 36961882 | PubTator, text mining | PubMed |
| Claudin and pancreatic cancer. | Front Oncol | 2023 | 36959784 | PubTator, text mining | PubMed |
| Adverse effect of assisted reproductive technology-related hyperoestrogensim on the secretion and absorption of uterine fluid in superovulating mice during the peri-implantation period. | Front Endocrinol (Lausanne) | 2023 | 36950692 | PubTator, text mining | PubMed |
| Transcriptome responses of intestinal epithelial cells induced by membrane vesicles of Listeria monocytogenes. | Curr Res Microb Sci | 2023 | 36942003 | PubTator, text mining | PubMed |
| Quantitative proteomics identified a novel invasion biomarker associated with EMT in pituitary adenomas. | Front Endocrinol (Lausanne) | 2023 | 36936141 | PubTator, text mining | PubMed |
| CLDN6 inhibits breast cancer metastasis through WIP-dependent actin cytoskeleton-mediated autophagy. | J Exp Clin Cancer Res | 2023 | 36935496 | PubTator, text mining | PubMed |
| Hepatotoxicity of polymeric proanthocyanidins is caused by translocation of bacterial lipopolysaccharides through impaired gut epithelium. | Toxicol Lett | 2023 | 36935082 | PubTator, text mining | PubMed |
| Paradoxical Reactions to Anti-TNFα and Anti-IL-17 Treatment in Psoriasis Patients: Are Skin and/or Gut Microbiota Involved? | Dermatol Ther (Heidelb) | 2023 | 36929119 | PubTator, text mining | PubMed |
| MARVELD3 inhibits the epithelial-mesenchymal transition and cell migration by suppressing the Wnt/β-catenin signaling pathway in non-small cell lung cancer cells. | Thorac Cancer | 2023 | 36924014 | PubTator, text mining | PubMed |
| Apical-Out Enteroids as an Innovative Model for Necrotizing Enterocolitis. | J Surg Res | 2023 | 36915002 | PubTator, text mining | PubMed |
| Synthetic biology-inspired cell engineering in diagnosis, treatment, and drug development. | Signal Transduct Target Ther | 2023 | 36906608 | PubTator, text mining | PubMed |
| Infantile human labial glands: Distribution of aquaporins and claudins in the context of paracellular and transcellular pathways. | Tissue Cell | 2023 | 36905859 | PubTator, text mining | PubMed |
Reliability of pathophysiological markers reflective of exercise-induced gastrointestinal syndrome (EIGS) in response to 2-h high-intensity interval exercise: A comprehensive methodological efficacy exploration. | Front Physiol | 2023 | 36895638 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1365/papers?page=19